First Trust NYSE Arca Bio... (FBT)
First Trust NYSE Arca Biotechnology Index Fund (FBT) Stock Price, Analysis & Data
| Бид | 269.15 |
| Рыночная капитализация | n/a |
| Выручка (TTM) | n/a |
| Чистая прибыль (TTM) | n/a |
| Бета | n/a |
| EPS (TTM) | n/a |
| P/E (TTM) | 28.93 |
| Прогнозный P/E | n/a |
| P/B (TTM) | 1.56 |
| P/S (TTM) | n/a |
| Earnings Date | n/a |
| Аск | 269.73 |
| Объём торгов | 6,270 |
| Ср. объём (20д) | 66,058 |
| Открытие | 265.83 |
| Пред. закрытие | 260.74 |
| Диапазон дня | 269.40 - 270.74 |
| Диапазон за 52 недели | 171.00 - 270.74 |
| Аналитики | n/a |
| Целевая цена | n/a |
| Дивиденды | n/a |
| Дата отсечки | n/a |
О компании FBT
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies....
Полный профиль компанииФинансовые результаты
В undefined году выручка First Trust NYSE Arca Biotechnology Index Fund составила n/a — это рост на undefined% к прошлогодним n/a. Прибыль составила n/a — это рост на undefined%.
Финансовая отчётность
3 недель назад · 24/7 Wall St.
FBT and IBB Are Not the Same Biotech Bet, and 5 Years of Returns Prove ItMost biotech investors treat FBT and IBB as two names for the same trade, but the structural differences buried in their index methodologies have produced shockingly different outcomes depending on wh...
7 месяцев назад · 24/7 Wall St.
Biotech Could Be One of 2026’s Biggest Winners, and This ETF Is Perfectly PositionedBiotech investors spent years waiting for the sector to recover from its brutal 2021 peak. That patience is finally paying off. First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) has surged...
